Browse > Article

Bioequivalenee of Samchundang Atenolol Tablet to Tenolmin Tablet  

Cho, Hea-Young (Institute of Bioequivalence and Bridging Study, College of Pharmacy, Chonnam National University)
Kang, Hyun-Ah (Institute of Bioequivalence and Bridging Study, College of Pharmacy, Chonnam National University)
Lee, Suk (Institute of Bioequivalence and Bridging Study, College of Pharmacy, Chonnam National University)
Baek, Seung-Hee (Institute of Bioequivalence and Bridging Study, College of Pharmacy, Chonnam National University)
Lee, Yong-Bok (Institute of Bioequivalence and Bridging Study, College of Pharmacy, Chonnam National University)
Publication Information
YAKHAK HOEJI / v.47, no.5, 2003 , pp. 339-344 More about this Journal
Abstract
Atenolol is a water soluble, ${\beta}_1$ selective adrenoceptor antagonist used in the treatment of angina and hypertension. It is primarily eliminated renally with minimal hepatic metabolism. The purpose of the present study was to evaluate the bioequivalence of Samchundang Atenolol (Samchundang Pharmaceutical Co., Korea.) to Tenolmin(Hyundai Pharmaceutical Ind. Co., Korea). The atenolol release from the two atenolol tablets in vitro was tested using KP VII Apparatus II method with various different kinds of dissolution media (pH 1.2, 4.0, 6.8 buffer solution and water). Twenty four normal male volunteers, 22.83$\pm$1.99 years in age and 65.82$\pm$7.15 kg in body weight, were divided into two groups and a randomized $2{\times}2$ cross-over study was employed. After one tablet containing 50 mg of atenolol was orally administered, blood was taken at predetermined time intervals and the concentrations of atenolol in serum were determined using HPLC method with fluorescence detector. The dissolution profiles of two atenolol tablets were very similar at all dissolution media. Besides, the pharmacokinetic parameters such as $AUC_{t}$, $C_{max}$ and $T_{max}$ were calculated and ANOVA test was utilized for the statistical analysis of the parameters using logarithmically transformed $AUC_{t}$ and $C_{max}$ and untransformed $T_{max}$. The results showed that the differences in $AUC_{t}$, $C_{max}$ and $T_{max}$ between two tablets based on the Tenolmin were 3.74%, 4.38% and 17.77%, respectively. There were no sequence effects between two tablets in these parameters. The 90% confidence intervals using logarithmically transformed data were within the acceptance range of log(0.8) to log(1.25) (e.g., log(0.98)∼log(1.l1) and log(0.95)∼log(1.l5) for $AUC_{t}$ and $C_{max}$ respectively), indicating that Samchundang Atenolol tablet is bioequivalent to Tenolmin tablet.
Keywords
atenolol; samchundang atenolol; tenolmin; dissolution; bioequivalence; HPLC;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Atenolol: pharmacokineric/dynamic aspects of comparative developmental toxicity /
[ Tabacova,S.A.;Kimmel,C.A. ] / Reprod Toxicol.
2 Bioequivalence of two tablet formulations of atenolol atfer single oral administration in healty volunteers /
[ Niopas,I.;Daftsions A. C.;Xanthakis,I.;Nikolaidis,N.;Njau,S.N. ] / Arzneim.-Forsch./Drug Res.
3 /
[ 식품의약품안전청 ] / 식품의약품안전청 고시 제 2002-60호, 생물학적동등성시험 기준
4 /
[ Parfitt,K. ] / Martindale - The complete Drug Reference(32nd ed.)
5 /
[ Statistical Solutions Ltd. ] / Equiv <TEX>$Test^?$</TEX> 1.0, U.K.
6 In vitro and in vivo equivalence of two oral atenolol tablet formulations /
[ Cuadrado,A.;Gascon,A.R.;Hernandez,R.M.;Castilla,A.M.;Maza,A.;Ocariz,A.L.;Calvo,B.;Pedraz,J.L. ] / Arzneim.-Forsch./Drug Res.